189 related articles for article (PubMed ID: 19115987)
1. Ethical consideration for use of carbapenems as treatment for sepsis due to carbapenem-resistant bacteria.
Cleveland KO; Gelfand MS
J Infect Dis; 2009 Jan; 199(2):289; discussion 289. PubMed ID: 19115987
[No Abstract] [Full Text] [Related]
2. Doripenem: an early look at a carbapenem not yet approved for pediatrics.
Overturf GD
Pediatr Infect Dis J; 2010 Feb; 29(2):163-5. PubMed ID: 20135831
[No Abstract] [Full Text] [Related]
3. New developments in carbapenems.
Kattan JN; Villegas MV; Quinn JP
Clin Microbiol Infect; 2008 Dec; 14(12):1102-11. PubMed ID: 19076841
[TBL] [Abstract][Full Text] [Related]
4. [STRATEGY OF ANTIBACTERIAL THERAPY OF SEPSIS. PART I].
Shapoval SD; Savon IL; Martyniuk VB; Vasylevska LA; Yakunych AM; Maksimova OO; Sofilkanych MM
Klin Khir; 2015 Jun; (6):62-6. PubMed ID: 26521472
[No Abstract] [Full Text] [Related]
5. Thymosin alpha1- and ulinastatin-based immunomodulatory strategy for sepsis arising from intra-abdominal infection due to carbapenem-resistant bacteria.
Zhang Y; Chen H; Li YM; Zheng SS; Chen YG; Li LJ; Zhou L; Xie HY; Praseedom RK
J Infect Dis; 2008 Sep; 198(5):723-30. PubMed ID: 18613793
[TBL] [Abstract][Full Text] [Related]
6. Doripenem: position in clinical practice.
Dedhia HV; McKnight R
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):507-14. PubMed ID: 19485791
[TBL] [Abstract][Full Text] [Related]
7. Carbapenem use in critically ill patients.
Patrier J; Timsit JF
Curr Opin Infect Dis; 2020 Feb; 33(1):86-91. PubMed ID: 31815750
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment with doripenem and tobramycin of ventriculitis due to imipenem- and meropenem-resistant Pseudomonas aeruginosa.
Gelfand MS; Cleveland KO; Mazumder SA
J Antimicrob Chemother; 2009 Jun; 63(6):1297-9. PubMed ID: 19369268
[No Abstract] [Full Text] [Related]
9. Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004.
Watanabe A; Tokue Y; Kikuchi T; Gomi K; Aoki S; Satoh T; Fujimura S
Int J Antimicrob Agents; 2005 Nov; 26(5):420-3. PubMed ID: 16216468
[No Abstract] [Full Text] [Related]
10. [Bacteremia at Ullvål Hospital 1977-1979. Types of bacteria and antibiotic sensitivity].
Maeland A
Tidsskr Nor Laegeforen; 1981 Aug; 101(23):1284-6. PubMed ID: 7268739
[No Abstract] [Full Text] [Related]
11. Doripenem (Doribax)--a new parenteral carbapenem.
Med Lett Drugs Ther; 2008 Jan; 50(1278):5-7. PubMed ID: 18219262
[No Abstract] [Full Text] [Related]
12. Antibiotic heterogeneity.
Masterton RG
Int J Antimicrob Agents; 2010 Nov; 36 Suppl 3():S15-8. PubMed ID: 21129627
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem resistance in Bacteroides fragilis.
Ang L; Brenwald NP; Walker RM; Andrews J; Fraise A
J Antimicrob Chemother; 2007 May; 59(5):1042-4. PubMed ID: 17363423
[No Abstract] [Full Text] [Related]
14. Investigation of carbapenem-resistant Acinetobacter baumannii isolates in a district hospital in Taiwan.
Chen CM; Liu PY; Ke SC; Wu HJ; Wu LT
Diagn Microbiol Infect Dis; 2009 Apr; 63(4):394-7. PubMed ID: 19302926
[TBL] [Abstract][Full Text] [Related]
15. Strategic Trials to Define the Best Available Treatment for Neonatal and Pediatric Sepsis Caused by Carbapenem-resistant Organisms.
Donà D; Sharland M; Heath PT; Folgori L
Pediatr Infect Dis J; 2019 Aug; 38(8):825-827. PubMed ID: 31261359
[TBL] [Abstract][Full Text] [Related]
16. [The value of guidelines for antibiotic administration in patients with sepsis].
Frissen PH; Cramer MJ; Ferwerda J
Ned Tijdschr Geneeskd; 1987 May; 131(22):967. PubMed ID: 3600829
[No Abstract] [Full Text] [Related]
17. ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumonia.
Morrissey I; Biek D; Janes R
J Antimicrob Chemother; 2009 Jul; 64(1):209-10. PubMed ID: 19429928
[No Abstract] [Full Text] [Related]
18. [Study of the value of guidelines for he use of antibiotics in patients with sepsis].
Admiraal JM; Lens EE; Pauw W
Ned Tijdschr Geneeskd; 1987 Mar; 131(13):527-9. PubMed ID: 3574512
[No Abstract] [Full Text] [Related]
19. [Drug selection for the treatment of sepsis].
Ono Y; Miyashita T; Kunii O
Nihon Rinsho; 1990 Oct; 48(10):2268-75. PubMed ID: 2280474
[No Abstract] [Full Text] [Related]
20. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii strains in intensive care units of multiple Mediterranean hospitals.
Giannouli M; Tomasone F; Agodi A; Vahaboglu H; Daoud Z; Triassi M; Tsakris A; Zarrilli R
J Antimicrob Chemother; 2009 Apr; 63(4):828-30. PubMed ID: 19223304
[No Abstract] [Full Text] [Related]
[Next] [New Search]
